← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2019-1:876 | 876 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol; Estradiol; Testosterone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:876 | 876 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:876 | 876 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-720 | 70004-720-12 | Lidocaine Hydrochloride | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:876 | 876 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:876 | 876 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:876 | 876 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73463-102 | 73463-102-03 | Ketamine Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:876 | 876 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:876 | 876 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-916 | 69852-916-10 | Methylprednisolone Acetate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:876 | 876 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0219 | 71285-0219-1 | Mannitol; Lidocaine Hydrochloride; Magnesium Sulfate Heptahydrate; Sodium Bicarbonate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:876 | 876 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-5402 | 72934-5402-4 | Lidocaine; Tetracaine | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:876 | 876 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-103 | 81375-103-40 | Mitomycin | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:876 | 876 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-097 | 71449-097-42 | Moxifloxacin Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:876 | 876 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9017 | 83826-9017-8 | Moxifloxacin Hydrochloride; Ketorolac Tromethamine; Prednisolone Sodium Phosphate | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:876 | 876 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5066 | 26436-5066-3 | Niacinamide | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:876 | 876 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2561 | 72934-2561-2 | Niacinamide; Tretinoin | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:877 | 877 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0040 | 73271-0040-1 | TESTOSTERONE 40 PEL | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:877 | 877 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol; Estradiol; Testosterone; Progesterone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:877 | 877 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:877 | 877 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-723 | 70004-723-09 | Lidocaine Hydrochloride | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:877 | 877 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6006 | 71286-6006-1 | Lidocaine Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:877 | 877 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9080 | 71266-9080-1 | Ketamine Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:877 | 877 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:877 | 877 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-418 | 70092-418-36 | Midazolam Hydrochloride | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:877 | 877 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-115 | 69852-115-10 | Methylprednisolone Acetate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:877 | 877 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0205 | 72196-0205-1 | Mannitol; Lidocaine Hydrochloride; Sodium Bicarbonate; Sodium Chloride; Potassium Chloride; Calcium Chloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:877 | 877 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2402 | 72934-2402-2 | Lidocaine; Tetracaine | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:877 | 877 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-100 | 81375-100-40 | Mitomycin | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:877 | 877 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79926-068 | 79926-068-05 | Moxifloxacin Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:877 | 877 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9014 | 83826-9014-5 | Moxifloxacin Hydrochloride; Prednisolone Sodium Phosphate; Bromfenac Sodium | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:877 | 877 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2547 | 72934-2547-2 | Niacinamide; Azelaic Acid | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:877 | 877 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2566 | 72934-2566-2 | Niacinamide; Tretinoin | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:878 | 878 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9091 | 71266-9091-1 | Lidocaine HCl 2% | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:878 | 878 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol; Estradiol; Testosterone; Progesterone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:878 | 878 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:878 | 878 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-024 | 71449-024-07 | Lidocaine Hydrochloride | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:878 | 878 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:878 | 878 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-521 | 69374-521-31 | Ketamine Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:878 | 878 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketoconazole | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:878 | 878 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-177 | 70092-177-35 | Midazolam Hydrochloride | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:878 | 878 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-2115 | 72907-2115-3 | Methylprednisolone Acetate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:878 | 878 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0205 | 71285-0205-1 | Mannitol; Lidocaine Hydrochloride; Sodium Bicarbonate; Sodium Chloride; Potassium Chloride; Calcium Chloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:878 | 878 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2402 | 72934-2402-4 | Lidocaine; Tetracaine | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:878 | 878 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8475 | 71266-8475-3 | Mitomycin | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:878 | 878 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8604 | 71266-8604-1 | Moxifloxacin Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:878 | 878 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride; Prednisolone Sodium Phosphate; Bromfenac Sodium | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:878 | 878 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2529 | 72934-2529-2 | Niacinamide; Calcipotriene | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:878 | 878 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2569 | 72934-2569-2 | Niacinamide; Tretinoin | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:879 | 879 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6488 | 71266-6488-3 | Omnipaque (Iohexol) 300 | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:879 | 879 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol; Estradiol; Testosterone; Progesterone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:879 | 879 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:879 | 879 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-024 | 71449-024-11 | Lidocaine Hydrochloride | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:879 | 879 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-985 | 69374-985-05 | Lidocaine Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:879 | 879 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-4000 | 72627-4000-2 | Ketamine Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:879 | 879 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79926-022 | 79926-022-10 | Ketoconazole | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:879 | 879 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-313 | 70092-313-50 | Midazolam Hydrochloride | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:879 | 879 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-2115 | 72907-2115-5 | Methylprednisolone Acetate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:879 | 879 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0111 | 71285-0111-1 | Mannitol; Magnesium Sulfate Heptahydrate; Sodium Chloride; Potassium Chloride; Magnesium Chloride; Tromethamine; Dextrose Monohydrate; Sodium Acetate; Sodium Gluconate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:879 | 879 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-3102 | 72627-3102-1 | Lidocaine; Tetracaine | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:879 | 879 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6412 | 71266-6412-3 | Mitomycin | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:879 | 879 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:879 | 879 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9016 | 83826-9016-8 | Moxifloxacin Hydrochloride; Prednisolone Sodium Phosphate; Bromfenac Sodium | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:879 | 879 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-3563 | 72934-3563-8 | Niacinamide; Clindamycin Phosphate | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:879 | 879 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2567 | 72934-2567-2 | Niacinamide; Tretinoin | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:880 | 880 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 79559-1100 | 79559-1100-1 | S-T100 | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:880 | 880 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol; Progesterone; 7-Keto-Dehydroepiandrosterone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:880 | 880 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:880 | 880 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:880 | 880 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride Anhydrous | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:880 | 880 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:880 | 880 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6442 | 71300-6442-2 | Ketoprofen | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:880 | 880 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-042 | 71506-042-56 | Midazolam Hydrochloride | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:880 | 880 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-1075 | 71266-1075-1 | Methylprednisolone Acetate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:880 | 880 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0111 | 72196-0111-1 | Mannitol; Magnesium Sulfate Heptahydrate; Sodium Chloride; Potassium Chloride; Magnesium Chloride; Tromethamine; Dextrose Monohydrate; Sodium Acetate; Sodium Gluconate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:880 | 880 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-2588 | 72682-2588-4 | Lidocaine; Tetracaine; Benzocaine | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:880 | 880 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:880 | 880 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8613 | 71266-8613-1 | Moxifloxacin Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:880 | 880 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride; Triamcinolone Acetonide | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:880 | 880 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2617 | 72934-2617-8 | Niacinamide; Clobetasol Propionate | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:880 | 880 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2568 | 72934-2568-2 | Niacinamide; Tretinoin | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:881 | 881 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0415 | 71285-0415-1 | Trophamine 2%/Dextrose 5% With Calcium Gluconate 3.75mEq and Heparin 125 units 250ml in 250ml bag | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:881 | 881 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol; Progesterone; 7-Keto-Dehydroepiandrosterone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:881 | 881 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:881 | 881 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:881 | 881 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride Anhydrous | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:881 | 881 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:881 | 881 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketoprofen; Betamethasone Dipropionate; Lidocaine Hydrochloride; Prilocaine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:881 | 881 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:881 | 881 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylprednisolone Acetate; Lidocaine | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:881 | 881 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Mannitol; Semaglutide | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:881 | 881 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1006 | 73271-1006-1 | Lidocaine; Tetracaine; Benzocaine | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:881 | 881 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-522 | 70092-522-35 | Morphine Sulfate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:881 | 881 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9034 | 83826-9034-5 | Moxifloxacin Hydrochloride; Bromfenac Sodium | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:881 | 881 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-5549 | 72934-5549-5 | Mupirocin; Metronidazole | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:881 | 881 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2586 | 72934-2586-2 | Niacinamide; Dapsone | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:881 | 881 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2546 | 72934-2546-2 | Niacinamide; Tretinoin | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:882 | 882 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73217-003 | 73217-003-10 | Tacrolimus 0.1% Ophth | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:882 | 882 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol; Progesterone; Estradiol | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:882 | 882 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:882 | 882 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:882 | 882 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-725 | 70004-725-09 | Lidocaine Hydrochloride Anhydrous | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:882 | 882 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-511 | 69374-511-01 | Ketamine Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:882 | 882 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0017 | 81483-0017-1 | Ketorolac Tromethamine | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:882 | 882 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:882 | 882 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-8025 | 73271-8025-1 | Methylprednisolone Acetate; Lidocaine | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:882 | 882 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Mannitol; Semaglutide | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:882 | 882 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-5405 | 72934-5405-4 | Lidocaine; Tetracaine; Benzocaine | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:882 | 882 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1020 | 73013-1020-1 | Morphine Sulfate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:882 | 882 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-259 | 81375-259-05 | Moxifloxacin Hydrochloride; Bromfenac Sodium | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:882 | 882 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0407 | 71285-0407-1 | N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Calcium Gluconate Monohydrate; Lysine Acetate; Serine; Tyrosine | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:882 | 882 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2615 | 72934-2615-2 | Niacinamide; Fluocinolone Acetonide | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:882 | 882 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2564 | 72934-2564-2 | Niacinamide; Tretinoin | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:883 | 883 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5497 | 26436-5497-5 | Trimix 30/30/2 | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:883 | 883 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol; Progesterone; Estradiol | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:883 | 883 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:883 | 883 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:883 | 883 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8088 | 71285-8088-1 | Lidocaine Hydrochloride Anhydrous | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:883 | 883 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-4001 | 72627-4001-2 | Ketamine Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:883 | 883 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-123 | 69852-123-10 | Ketorolac Tromethamine | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:883 | 883 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-032 | 70092-032-50 | Midazolam Hydrochloride | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:883 | 883 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9190 | 71266-9190-1 | Midazolam | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:883 | 883 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-539 | 69374-539-03 | Methacholine Chloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:883 | 883 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1012 | 73271-1012-1 | Lidocaine; Tetracaine; Phenylephrine; Prilocaine | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:883 | 883 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-242 | 73702-242-32 | Morphine Sulfate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:883 | 883 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride; Dexamethasone Sodium Phosphate | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:883 | 883 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5558 | 26436-5558-5 | Nadide | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:883 | 883 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1533 | 72934-1533-2 | Niacinamide; Ivermectin; Metronidazole | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:883 | 883 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2564 | 72934-2564-4 | Niacinamide; Tretinoin | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:884 | 884 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-020 | 73198-020-03 | QM-4 | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:884 | 884 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol; Progesterone; Estradiol | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:884 | 884 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-512 | 69374-512-25 | Lidocaine Hydrochloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:884 | 884 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-947 | 69374-947-01 | Lidocaine Hydrochloride | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:884 | 884 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8089 | 71285-8089-1 | Lidocaine Hydrochloride Anhydrous | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:884 | 884 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-513 | 69374-513-50 | Ketamine Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:884 | 884 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketorolac Tromethamine; Clonidine Hydrochloride; Ropivacaine Hydrochloride; Racepinephrine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:884 | 884 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-312 | 70092-312-75 | Midazolam Hydrochloride | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:884 | 884 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9190 | 71266-9190-2 | Midazolam | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:884 | 884 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-380 | 70004-380-05 | Methadone Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:884 | 884 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5436 | 26436-5436-1 | Liothyronine Sodium | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:884 | 884 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-156 | 82396-156-25 | Morphine Sulfate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:884 | 884 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9004 | 83826-9004-1 | Moxifloxacin Hydrochloride; Dexamethasone Sodium Phosphate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:884 | 884 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5558 | 26436-5558-0 | Nadide | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:884 | 884 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1532 | 72934-1532-2 | Niacinamide; Ivermectin; Metronidazole; Brimonidine Tartrate | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:884 | 884 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1564 | 72934-1564-2 | Niacinamide; Tretinoin | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:885 | 885 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5055 | 71266-5055-2 | Hydromorphone HCl | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:885 | 885 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol; Progesterone; Estradiol | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:885 | 885 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-947 | 69374-947-01 | Lidocaine Hydrochloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:885 | 885 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:885 | 885 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5480 | 26436-5480-1 | Lidocaine Hydrochloride Anhydrous | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:885 | 885 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:885 | 885 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Kojic Acid; Hyaluronic Acid; Ascorbic Acid | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:885 | 885 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-130 | 71449-130-32 | Midazolam Hydrochloride | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:885 | 885 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9190 | 71266-9190-5 | Midazolam | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:885 | 885 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methadone Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:885 | 885 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5381 | 26436-5381-1 | Liothyronine Sodium | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:885 | 885 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-159 | 82396-159-01 | Morphine Sulfate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:885 | 885 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9017 | 83826-9017-8 | Moxifloxacin Hydrochloride; Ketorolac Tromethamine; Prednisolone Sodium Phosphate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:885 | 885 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nadide | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:885 | 885 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2525 | 72934-2525-2 | Niacinamide; Lactic Acid | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:885 | 885 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1545 | 72934-1545-2 | Niacinamide; Tretinoin | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:886 | 886 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-050 | 71170-050-05 | Ketamine 50 mg per 5 mL Syringe (10 mg/mL) | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:886 | 886 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol; Progesterone; Estradiol | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:886 | 886 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-985 | 69374-985-05 | Lidocaine Hydrochloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:886 | 886 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-985 | 69374-985-05 | Lidocaine Hydrochloride | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:886 | 886 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6290 | 71266-6290-1 | Lidocaine Hydrochloride; Epinephrine Bitartrate; Tetracaine Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:886 | 886 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-982 | 69374-982-55 | Ketamine Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:886 | 886 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 65302-503 | 65302-503-04 | Labetalol Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:886 | 886 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:886 | 886 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-106 | 73177-106-04 | Midazolam | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:886 | 886 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-161 | 70092-161-43 | Methadone Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:886 | 886 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5243 | 26436-5243-1 | Liothyronine Sodium | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:886 | 886 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-022 | 71449-022-32 | Morphine Sulfate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:886 | 886 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9014 | 83826-9014-5 | Moxifloxacin Hydrochloride; Prednisolone Sodium Phosphate; Bromfenac Sodium | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:886 | 886 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5642 | 26436-5642-1 | Nadide | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:886 | 886 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1595 | 72934-1595-2 | Niacinamide; Levocetirizine Dihydrochloride; Imiquimod | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:886 | 886 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nicotinamide Adenine Dinucleotide | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:887 | 887 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-056 | 70092-056-05 | Vancomycin PF 1.5g add to 250ml NS bag | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:887 | 887 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol; Progesterone; Estradiol | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:887 | 887 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-949 | 69374-949-05 | Lidocaine Hydrochloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:887 | 887 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6006 | 71286-6006-1 | Lidocaine Hydrochloride | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:887 | 887 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Epinephrine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:887 | 887 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-982 | 69374-982-33 | Ketamine Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:887 | 887 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-700 | 70004-700-28 | Labetalol Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:887 | 887 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-4036 | 71286-4036-1 | Midazolam Hydrochloride | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:887 | 887 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-106 | 73177-106-05 | Midazolam | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:887 | 887 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2441 | 72627-2441-1 | Methionine; Choline Chloride; Cyanocobalamin | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:887 | 887 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-145 | 82396-145-25 | Lorazepam | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:887 | 887 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-523 | 70092-523-50 | Morphine Sulfate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:887 | 887 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9016 | 83826-9016-8 | Moxifloxacin Hydrochloride; Prednisolone Sodium Phosphate; Bromfenac Sodium | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:887 | 887 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nadide | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:887 | 887 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2573 | 72934-2573-2 | Niacinamide; Oxymetazoline Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:887 | 887 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nicotinamide Adenine Dinucleotide | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:888 | 888 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-100 | 70092-100-50 | Fentanyl PF 50 mcg/ml 55 ml- 60 ml syr | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:888 | 888 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol; Progesterone; Estradiol | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:888 | 888 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:888 | 888 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-535 | 69374-535-50 | Lidocaine Hydrochloride | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:888 | 888 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1502 | 73271-1502-1 | Lidocaine Hydrochloride; Medroxyprogesterone Acetate | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:888 | 888 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-519 | 69374-519-50 | Ketamine; Ketorolac Tromethamine; Ropivacaine Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:888 | 888 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Labetalol Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:888 | 888 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-4035 | 71286-4035-3 | Midazolam Hydrochloride | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:888 | 888 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5030 | 71266-5030-1 | Midazolam | 2022-2 | valid | 0 | 2026-10-17 |